Published in Arch Pediatr Adolesc Med on December 01, 1999
Mental health services for youths in foster care and disabled youths. Am J Public Health (2001) 2.01
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ (2012) 1.22
Physicians' shared decision-making behaviors in attention-deficit/hyperactivity disorder care. Arch Pediatr Adolesc Med (2011) 1.13
State infant/toddler program policies for eligibility and services provision for young children with autism. Adm Policy Ment Health (2007) 1.10
Shared decision-making to improve attention-deficit hyperactivity disorder care. Patient Educ Couns (2013) 1.01
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J Am Acad Child Adolesc Psychiatry (2008) 0.98
Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes (2013) 0.96
The myADHDportal.com Improvement Program: An innovative quality improvement intervention for improving the quality of ADHD care among community-based pediatricians. Clin Pract Pediatr Psychol (2013) 0.94
Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands. Eur Child Adolesc Psychiatry (2009) 0.90
Survey of mental health consultation and referral among primary care pediatricians. Acad Pediatr (2009) 0.90
Variability in ADHD care in community-based pediatrics. Pediatrics (2014) 0.90
Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications. Curr Psychiatry Rep (2013) 0.90
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder. PLoS One (2012) 0.88
Gender and injuries predict stimulant medication use. J Child Adolesc Psychopharmacol (2014) 0.84
Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder. Expert Rev Neurother (2011) 0.83
Parent-teacher agreement on ADHD symptoms across development. Psychol Assess (2014) 0.82
Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence. Child Adolesc Psychiatry Ment Health (2007) 0.79
Disparities in identification of comorbid diagnoses in children with ADHD. Clin Pediatr (Phila) (2014) 0.76
Competition and the mental health system. Am J Psychiatry (2009) 0.75
The difference between efficacy and effectiveness research in studying attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (1999) 0.75
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (2000) 5.44
Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA (1998) 5.09
Trends in the prescribing of psychotropic medications to preschoolers. JAMA (2000) 5.02
Tn4351 transposes in Bacteroides spp. and mediates the integration of plasmid R751 into the Bacteroides chromosome. J Bacteriol (1986) 3.90
Evidence that the clindamycin-erythromycin resistance gene of Bacteroides plasmid pBF4 is on a transposable element. J Bacteriol (1985) 3.45
A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med (1989) 2.94
Regulation of the threonine operon: tandem threonine and isoleucine codons in the control region and translational control of transcription termination. Proc Natl Acad Sci U S A (1979) 2.77
Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 2.68
Personal protection against sexually transmitted diseases. Am J Obstet Gynecol (1986) 2.34
Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J Am Acad Child Adolesc Psychiatry (1998) 2.30
Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology (2001) 2.19
Use of randomly cloned DNA fragments for identification of Bacteroides thetaiotaomicron. J Bacteriol (1983) 2.17
Role of Escherichia coli IHF protein in lambda site-specific recombination. A mutational analysis of binding sites. J Mol Biol (1986) 2.13
Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum (2000) 2.06
Mental health services for youths in foster care and disabled youths. Am J Public Health (2001) 2.01
Biocidal activities of glutaraldehyde and related compounds. J Appl Bacteriol (1967) 1.89
A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 1.82
Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study. Am J Public Health (1989) 1.77
Primary prevention of sexually transmitted diseases. A primer for clinicians. JAMA (1986) 1.75
Integration and excision of a Bacteroides conjugative transposon, CTnDOT. J Bacteriol (2000) 1.67
Extent of sequence homology required for bacteriophage lambda site-specific recombination. J Mol Biol (1985) 1.62
Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry (2000) 1.61
Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. J Clin Microbiol (2001) 1.60
A comparison of the effects of single-base and triple-base changes in the integrase arm-type binding sites on the site-specific recombination of bacteriophage lambda. Nucleic Acids Res (1990) 1.57
Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. Radiology (1997) 1.52
Complementation of bacteriophage lambda integrase mutants: evidence for an intersubunit active site. EMBO J (1993) 1.50
Mapping the functional domains of bacteriophage lambda integrase protein. J Mol Biol (1994) 1.47
Genetic analysis of bacteriophage lambda integrase interactions with arm-type attachment site sequences. J Bacteriol (1990) 1.45
Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis (2010) 1.43
Identification of genes required for excision of CTnDOT, a Bacteroides conjugative transposon. Mol Microbiol (2001) 1.43
Mutations in an integration host factor-binding site: effect on lambda site-specific recombination and regulatory implications. J Bacteriol (1986) 1.42
Mutational analysis of integrase arm-type binding sites of bacteriophage lambda. Integration and excision involve distinct interactions of integrase with arm-type sites. J Mol Biol (1986) 1.39
Genetic analysis of Escherichia coli integration host factor interactions with its bacteriophage lambda H' recognition site. J Bacteriol (1991) 1.36
Identification and restriction endonuclease mapping of the threonine operon regulatory region. J Mol Biol (1978) 1.35
RsaI: a new sequence-specific endonuclease activity from Rhodopseudomonas sphaeroides. J Bacteriol (1980) 1.34
Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry (1998) 1.34
A genetic enrichment for mutations constructed by oligodeoxynucleotide-directed mutagenesis. Gene (1985) 1.33
Initiation, pausing, and termination of transcription in the threonine operon regulatory region of Escherichia coli. J Biol Chem (1982) 1.31
DNA interactions during bacteriophage lambda site-specific recombination. Cold Spring Harb Symp Quant Biol (1984) 1.30
Characterization of the bacteriophage lambda excisionase (Xis) protein: the C-terminus is required for Xis-integrase cooperativity but not for DNA binding. EMBO J (1992) 1.30
Contributions of RNA secondary structure and length of the thymidine tract to transcription termination at the thr operon attenuator. J Biol Chem (1988) 1.29
The isolation and characterization of mutants of the integration host factor (IHF) of Escherichia coli with altered, expanded DNA-binding specificities. EMBO J (1992) 1.28
Role of homology in site-specific recombination of bacteriophage lambda: evidence against joining of cohesive ends. Proc Natl Acad Sci U S A (1987) 1.27
Determining the DNA sequence elements required for binding integration host factor to two different target sites. J Bacteriol (1994) 1.25
Demographic and socioeconomic predictors of dental care utilization. J Am Dent Assoc (1998) 1.23
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (2008) 1.23
Direct genetic selection for a specific RNA-protein interaction. Nucleic Acids Res (1993) 1.19
Characterization of a site-specific restriction endonuclease from Rhodopseudomonas sphaeroides. J Bacteriol (1979) 1.13
A genetic analysis of Xis and FIS interactions with their binding sites in bacteriophage lambda. J Bacteriol (1991) 1.13
Transcription termination by bacteriophage T7 RNA polymerase at rho-independent terminators. J Biol Chem (1990) 1.08
Eight-year outcome associated with clinical options in the management of femoral neck fractures. Clin Orthop Relat Res (1998) 1.07
Growth rebound after termination of stimulant drugs. J Pediatr (1975) 1.06
Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull (1997) 1.06
Operator-promoter functions in the threonine operon of Escherichia coli. J Bacteriol (1975) 1.05
Attenuation regulation in the thr operon of Escherichia coli K-12: molecular cloning and transcription of the controlling region. J Bacteriol (1982) 1.04
Clinical decision consultation service. Am J Med (1986) 1.04
Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations. Lupus (2007) 1.04
Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum (1999) 1.03
Integration host factor facilitates repression of the put operon in Salmonella typhimurium. Gene (1992) 1.03
Specificity determinants for bacteriophage Hong Kong 022 integrase: analysis of mutants with relaxed core-binding specificities. Mol Microbiol (2000) 1.03
Secondary-site attachment of coliphage lambda near the thr operon. J Mol Biol (1974) 1.02
Genetic analysis of the bacteriophage lambda attL nucleoprotein complex. Genetics (1996) 1.01
Peering into the 'black box'. Measuring outcomes of managed care. Arch Gen Psychiatry (1996) 1.01
Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Arch Gen Psychiatry (1999) 1.01
The specific binding of Escherichia coli integration host factor involves both major and minor grooves of DNA. Biochemistry (1995) 1.00
Defining the structural and functional roles of the carboxyl region of the bacteriophage lambda excisionase (Xis) protein. J Mol Biol (1998) 1.00
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Examining the contribution of a dA+dT element to the conformation of Escherichia coli integration host factor-DNA complexes. Nucleic Acids Res (1996) 0.99
The effect of attachment site mutations on strand exchange in bacteriophage lambda site-specific recombination. Genetics (1989) 0.99
"A familial factor in minimal brain dysfunction. Behav Genet (1973) 0.98
Effect of center- versus patient-specific factors on variations in dialysis adequacy. J Am Soc Nephrol (2001) 0.97
Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics (1973) 0.97
Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol (1998) 0.95
Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis (2004) 0.95
Sutures and disasters in tonsillectomy. Arch Otolaryngol (1968) 0.93
Self-reported anxiety, general medical conditions, and disability bed days. Am J Psychiatry (1997) 0.93
Analysis of estrogen response element binding by genetically selected steroid receptor DNA binding domain mutants exhibiting altered specificity and enhanced affinity. J Biol Chem (1999) 0.93
"Clinical significance" and DSM-IV. Arch Gen Psychiatry (1998) 0.93
The central effects of scopolamine in man. Biol Psychiatry (1971) 0.92
Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women. Neurology (2001) 0.92
Stroke location is not associated with return to work after first ischemic stroke. Stroke (1999) 0.92
Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc (2011) 0.92
Condom use with regular and casual partners among women attending family planning clinics. Fam Plann Perspect (1992) 0.91
Serotype distribution of Salmonella isolates from food animals after slaughter differs from that of isolates found in humans. J Infect Dis (2001) 0.91
Identification and characterization of mutants affecting transcription termination at the threonine operon attenuator. J Mol Biol (1985) 0.91
Transcription termination in vitro by bacteriophage T7 RNA polymerase. The role of sequence elements within and surrounding a rho-independent transcription terminator. J Biol Chem (1992) 0.91
Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. Am J Psychiatry (1999) 0.91
Secondary lambda attachment site in the threonine operon attenuator of Escherichia coli. J Bacteriol (1981) 0.90
Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatr Serv (1998) 0.90
Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus (2008) 0.89
Services and prevention: pharmacoepidemiology of antidepressant use. Biol Psychiatry (2001) 0.89
Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol Oncol (2000) 0.89
Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases. Lupus (2008) 0.88